These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6443872)

  • 21. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cellwall vaccine in prophylaxis of tuberculosis.
    Pal DP; Shriniwas
    Indian J Med Res; 1977 Mar; 65(3):340-5. PubMed ID: 411743
    [No Abstract]   [Full Text] [Related]  

  • 23. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.
    Diel R; Nienhaus A; Lange C; Meywald-Walter K; Forssbohm M; Schaberg T
    Respir Res; 2006 May; 7(1):77. PubMed ID: 16707012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.
    Pym AS; Brodin P; Majlessi L; Brosch R; Demangel C; Williams A; Griffiths KE; Marchal G; Leclerc C; Cole ST
    Nat Med; 2003 May; 9(5):533-9. PubMed ID: 12692540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonliving immunogenic substances of Mycobacteria.
    Smith DW; Grover AA; Wiegeshaus E
    Bibl Tuberc; 1968; 24():191-227. PubMed ID: 4983194
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental study on BCG vaccination in the respiratory tract, with special reference to a comparison with other vaccination methods. 2. Reaction of the BCG vaccinated animals toward virulent Mycobacterium tuberculosis].
    Miyajima H
    Nihon Shonika Gakkai Zasshi; 1965 Jul; 69(7):632-9. PubMed ID: 4957082
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration.
    Giri PK; Verma I; Khuller GK
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):233-41. PubMed ID: 16831210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tuberculosis prevention by BCG vaccine].
    Hashimoto T
    Kekkaku; 1982 Jun; 57(6):329-34. PubMed ID: 6757514
    [No Abstract]   [Full Text] [Related]  

  • 29. BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components.
    Watanabe Y; Watari E; Matsunaga I; Hiromatsu K; Dascher CC; Kawashima T; Norose Y; Shimizu K; Takahashi H; Yano I; Sugita M
    Vaccine; 2006 Jul; 24(29-30):5700-7. PubMed ID: 16725232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCG: protection against infection with Mycobacterium tuberculosis.
    Mohapatra PR; Janmeja AK
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):825; author reply 826. PubMed ID: 16848348
    [No Abstract]   [Full Text] [Related]  

  • 31. [The type of vaccine].
    Blasi A
    Lotta Tuberc; 1968; 38(1):84-90. PubMed ID: 5252512
    [No Abstract]   [Full Text] [Related]  

  • 32. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
    Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
    Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in tuberculosis vaccine strategies.
    Skeiky YA; Sadoff JC
    Nat Rev Microbiol; 2006 Jun; 4(6):469-76. PubMed ID: 16710326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On some experimental aspects of antituberculosis vaccination with BCG].
    Di Perna A; Ciaccia A; Rabinovici A
    Lotta Tuberc; 1967; 37(3):Suppl:187-203. PubMed ID: 5252289
    [No Abstract]   [Full Text] [Related]  

  • 37. [Humoral and cellular immunity in response to BCG vaccination. A study of a sample of students of the Campania region].
    Liguori G; Maselli R; Di Benedetto R; de Angelis CP; Marinelli A; Marinelli P
    Ann Ig; 1998; 10(1):25-34. PubMed ID: 9616975
    [No Abstract]   [Full Text] [Related]  

  • 38. Differential activation of alveolar and peritoneal macrophages from BCG-vaccinated guinea pigs.
    Cho H; de Haas R; Jeevan A; McMurray DN
    Tuberculosis (Edinb); 2008 Jul; 88(4):307-16. PubMed ID: 18165156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
    Giri PK; Verma I; Khuller GK
    J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of thymus preparations on the efficacy of postvaccinal immunity in experimental tuberculosis].
    Kononko IV
    Fiziol Zh (1978); 1986; 32(4):478-81. PubMed ID: 3743824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.